1. Beyond the Ivory Tower: Outcomes Following Surgery for Ampullary Cancer

   • Andrew M. Lowy

   Hepatic and Pancreatic Tumors Open access 19 April 2008 Pages: 1813 - 1814

2. Is Lymphatic Mapping in Uterine Cancer Feasible?

   • Michael Frumovitz
   • Charles F. Levenback

   Gynecologic Oncology 13 May 2008 Pages: 1815 - 1817

3. Cancer Clinical Trials Accrual: Missed Opportunities to Address Disparities and Missed Opportunities to Improve Outcomes for All

   • Lisa A. Newman
   • Nathalie Kim Roff
   • Armin D. Weinberg

   Healthcare Policy and Outcomes Open access 19 April 2008 Pages: 1818 - 1819

4. Survival After Resection of Ampullary Carcinoma: A National Population-Based Study

   • Jessica B. O’Connell
   • Melinda A. Maggard
   • O. Joe Hines

   Healthcare Policy and Outcomes 28 March 2008 Pages: 1820 - 1827

   

5. Urban/Rural Residence Moderates Effect of Race on Receipt of Surgery in Patients with Nonmetastatic Breast Cancer: A Report from the South Carolina Central Cancer Registry

   • N. F. Esnaola
   • K. Knott
   • M. E. Ford

   Healthcare Policy and Outcomes 09 April 2008 Pages: 1828 - 1836

   

6. Certificate of Need Regulations and the Availability and Use of Cancer Resections

   • Marah N. Short
   • Thomas A. Aloia
   • Vivian Ho

   Healthcare Policy and Outcomes 06 May 2008 Pages: 1837 - 1845

   

7. Health-Related Quality of Life Outcomes in Disease-Free Survivors of Mid-Low Rectal Cancer After Curative Surgery

   • Salvatore Pucciarelli
   • Paola Del Bianco
   • Donato Nitti

   Healthcare Policy and Outcomes 06 May 2008 Pages: 1846 - 1854

   

8. Angiography is Indicated for Every Sentinel Bleed after Pancreaticoduodenectomy

   • Yu-Wen Tien
   • Yao-Ming Wu
   • Po-Huang Lee

   Hepatic and Pancreatic Tumors 16 April 2008 Pages: 1855 - 1861

9. Intraoperative Radiofrequency Ablation for Hepatocellular Carcinoma: Long-Term Results in a Large Series

   • Young-sun Kim
   • Hyunchul Rhim
   • Sung Joo Kim

   Hepatic and Pancreatic Tumors 08 May 2008 Pages: 1862 - 1870

   

10. A New Technique of Biliary Reconstruction After “High Hilar Resection” of Hilar Cholangiocarcinoma with Tumor Extension to Secondary and Tertiary Biliary Radicals

    • Unal Aydin
    • Suleyman Yedibela
    • Ahmet Coker

    Hepatic and Pancreatic Tumors 03 May 2008 Pages: 1871 - 1879

    

11. Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma: A Western Experience

    • Nazario Portolani
    • Gian Luca Baiocchi
    • Stefano Maria Giulini

    Hepatic and Pancreatic Tumors 29 April 2008 Pages: 1880 - 1890

    

12. Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases

    • Liselot B. J. van Iersel
    • Ellen J. Hoekman
    • Cornelis J. H. van de Velde

    Gastrointestinal Oncology Open access 10 May 2008 Pages: 1891 - 1898

    

13. Portal Vein Segmentation of a 3D-Planning System for Liver Surgery—In vivo Evaluation in a Porcine Model

    • Kai S. Lehmann
    • Joerg-P. Ritz
    • Bernd B. Frericks

    Hepatic and Pancreatic Tumors 01 May 2008 Pages: 1899 - 1907

    

14. Major Hepatectomy for Colorectal Metastases: Is Preoperative Portal Occlusion an Oncological Risk Factor?

    • L. Mueller
    • C. Hillert
    • D. C. Broering

    Hepatic and Pancreatic Tumors 06 May 2008 Pages: 1908 - 1917

    

15. Visceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer

    • Hyeong-Gon Moon
    • Young-Tae Ju
    • Sang-Kyung Choi

    Gastrointestinal Oncology 05 April 2008 Pages: 1918 - 1922

    

16. Predictors of Multivisceral Resection in Patients with Locally Advanced Colorectal Cancer

    • Anand Govindarajan
    • Novlette Fraser
    • Anna R. Gagliardi

    Gastrointestinal Oncology 13 May 2008 Pages: 1923 - 1930

17. Diabetes Mellitus Affects Response to Neoadjuvant Chemoradiotherapy in the Management of Rectal Cancer

    • A. S. Caudle
    • H. J. Kim
    • M. O. Meyers

    Gastrointestinal Oncology 17 April 2008 Pages: 1931 - 1936

18. Radical Resection After IORT-Containing Multimodality Treatment is the Most Important Determinant for Outcome in Patients Treated for Locally Recurrent Rectal Cancer

    • Raphaëla C. Dresen
    • Marleen J. Gosens
    • Harm J. Rutten

    Gastrointestinal Oncology Open access 04 April 2008 Pages: 1937 - 1947

    

19. Squamous Cell Carcinoma of the Anal Canal: Utilization and Outcomes of Recommended Treatment in the United States

    • Karl Y. Bilimoria
    • David J. Bentrem
    • Amy L. Halverson

    Gastrointestinal Oncology 15 April 2008 Pages: 1948 - 1958

    

20. Tumor Diameter as a Prognostic Factor in Patients with Gastric Cancer

    • Chikara Kunisaki
    • Hirochika Makino
    • Hiroshi Shimada

    Gastrointestinal Oncology 28 March 2008 Pages: 1959 - 1967

    

21. The Global Histone Modification Pattern Correlates with Cancer Recurrence and Overall Survival in Gastric Adenocarcinoma

    • Young Soo Park
    • Min Young Jin
    • Se Jin Jang

    Gastrointestinal Oncology 10 May 2008 Pages: 1968 - 1976

    

22. Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor

    • Masahiko Koike
    • Yasuhiro Kodera
    • Akimasa Nakao

    Gastrointestinal Oncology 12 April 2008 Pages: 1977 - 1982

    

23. Poor Hormone Receptor Expression in East African Breast Cancer: Evidence of a Biologically Different Disease?

    • P. A. Bird
    • A. G. Hill
    • N. Houssami

    Breast Oncology 12 April 2008 Pages: 1983 - 1988

24. Genomic Alterations Associated with Early Stages of Breast Tumor Metastasis

    • Rachel E. Ellsworth
    • Darrell L. Ellsworth
    • Craig D. Shriver

    Breast Oncology 10 April 2008 Pages: 1989 - 1995

    

25. Long-Term Morbidity of Sentinel Node Biopsy Versus Complete Axillary Dissection for Unilateral Breast Cancer

    • Rebecca Crane-Okada
    • Robert A. Wascher
    • Armando E. Giuliano

    Breast Oncology 16 April 2008 Pages: 1996 - 2005

    

26. A Prospective, Blinded Trial of Touch Prep Analysis versus Frozen Section for Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer

    • Kimberly A. Vanderveen
    • Rajendra Ramsamooj
    • Richard J. Bold

    Breast Oncology 15 May 2008 Pages: 2006 - 2011

    

27. Comparison of Laparoscopy and Laparotomy in Surgical Staging of Early-Stage Ovarian and Fallopian Tubal Cancer

    • Jeong-Yeol Park
    • Dae-Yeon Kim
    • Joo-Hyun Nam

    Gynecologic Oncology 25 April 2008 Pages: 2012 - 2019

28. Extent of Prophylactic Lymph Node Dissection in the Central Neck Area of the Patients with Papillary Thyroid Carcinoma: Comparison of Limited Versus Comprehensive Lymph Node Dissection in a 2-Year Safety Study

    • Young-Ik Son
    • Han-Sin Jeong
    • Jeesun Choi

    Endocrine Tumors 06 May 2008 Pages: 2020 - 2026

    

29. The Functional Impact on Voice of Sternothyroid Muscle Division During Thyroidectomy

    • Leonard R. Henry
    • Nancy Pearl Solomon
    • Alexander Stojadinovic

    Endocrine Tumors 06 May 2008 Pages: 2027 - 2033

    

30. A Single-Institution Validation of the AJCC Staging System for Stage IV Melanoma

    • Heather B. Neuman
    • Ami Patel
    • Daniel G. Coit

    Melanomas 09 May 2008 Pages: 2034 - 2041

    

31. Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor Metastasis

    • Marganit Benish
    • Inbal Bartal
    • Shamgar Ben-Eliyahu

    Gastrointestinal Oncology 09 April 2008 Pages: 2042 - 2052

    

32. Lesions of “Uncertain Malignant Potential” Diagnosed by Vacuum-Assisted Breast Biopsy: An Unclear Management?

    • George Zografos
    • Flora Zagouri
    • Effstratios Patsouris

    Breast Oncology 19 April 2008 Pages: 2053 - 2054

33. Management of B3 Lesions and Breast Biopsies

    • Mary F. Dillon
    • Enda W. Mc Dermott
    • Cecily M. Quinn

    Breast Oncology 07 May 2008 Pages: 2055 - 2056

34. Inhibition of Proliferation to Omega-3 Fatty Acids in Chemoresistant Pancreatic Cancer Cells: Mechanism of Action May be More Complex

    • Raj Persaud

    Hepatic and Pancreatic Tumors 20 March 2008 Pages: 2057 - 2057

35. Dendritic Cell Enumeration

    • Martin McCarter

    Melanomas 18 March 2008 Pages: 2058 - 2058

36. Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

    • Sabrina Irmscher
    • Norbert Senninger
    • Christina Schleicher

    Medical Oncology 12 February 2008 Pages: 2059 - 2060

37. Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

    • Daniel H. Palmer
    • Deborah D. Stocken
    • Simon R. Bramhall

    Hepatic and Pancreatic Tumors 10 May 2008 Pages: 2061 - 2061

38. Can Intraoperative Intraperitoneal Free Cancer Cell Detection Techniques Identify Patients at Higher Recurrence Risk Following Curative Colorectal Cancer Resection? A Meta-Analysis

    • Mesut Tez

    Hepatic and Pancreatic Tumors 14 March 2008 Pages: 2062 - 2062

39. A Place for Radiofrequency Ablation in the Treatment of Resectable Colorectal Liver Metastases?

    • V. E. de Meijer
    • J. N. M. IJzermans
    • C. Verhoef

    Gastrointestinal Oncology Open access 08 March 2008 Pages: 2063 - 2063

40. A Place for Radiofrequency Ablation in the Treatment of Resectable Colorectal Liver Metastases?

    • Stefaan Mulier
    • Theo Ruers
    • Yicheng Ni

    Gastrointestinal Oncology 10 May 2008 Pages: 2064 - 2065

41. Botulinum Toxin: A Novel Adjuvant for Giant Cell Tumor

    • Hamid Namazi

    Bone and Soft Tissue Sarcomas 29 December 2007 Pages: 2066 - 2067